The Utility of a Digital Glucose-Like Peptide-1 Receptor Agonist-Supported Weight-Loss Service in Regional Australia: A Qualitative Analysis of Interviews With Current Patients of the Eucalyptus Program.

OBJECTIVE

Against the backdrop of alarming obesity rates and growing concerns about access to specialist care across Australia, this study aims to assess the utility of the nation's largest digital weight-loss service (DWLS) in regional Australia.

SETTING

This study focuses on patients of the Eucalyptus DWLS who live in regional Australia (Monash Modified Model classification 3-6).

PARTICIPANTS

Thirty-two adults living with overweight or obesity who have been subscribed to the Eucalyptus DWLS for at least 3 weeks were invited to participate in phone-based interviews.

DESIGN

Interviewers prompted discussion around 6 questions, pertaining to reasons for Eucalyptus subscription, previous attempts at weight loss, views on the service's comprehensiveness, access to face-to-face alternatives, areas for program improvement and general program satisfaction. Investigators conducted a Braun and Clarke thematic analysis of all interview transcripts.

RESULTS

Six key themes were identified in the analysis, including unmanageable travel times to face-to-face obesity services; inadequate Eucalyptus app functionality; satisfaction with Eucalyptus care continuity; frustration with previously attempted standalone lifestyle interventions; aversion to or dissatisfaction with surgical interventions; and early weight loss increases confidence and exercise motivation.

CONCLUSION

Comprehensive DWLSs such as Eucalyptus have the potential to significantly increase access and adherence to continuous obesity care for regional Australians. However, platforms need to contain special provisions for users with lower literacy and integrate advanced lifestyle trackers to ensure patients are not simply using the DWLS to access weight-loss medications.